[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe RNAi for Therapeutic Market Report 2016

October 2016 | 123 pages | ID: EDEE600EF16EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of RNAi for Therapeutic

Revenue, means the sales value of RNAi for Therapeutic

This report studies sales (consumption) of RNAi for Therapeutic in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Alnylam Pharmaceuticals
  • Arbutus Biopharma (Tekmira)
  • Arrowhead Research
  • Dicerna Pharmaceuticals
  • Mirna Therapeutics
  • Quark Pharmaceuticals
  • RXi Pharmaceuticals
  • Silence Therapeutics
  • Benitec Biopharma
  • Miragen Therapeutics
  • Sylentis
  • Gradalis
  • Sirnaomics
  • Silenseed
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of RNAi for Therapeutic in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • siRNA
  • miRNA
  • shRNA
Split by application, this report focuses on sales, market share and growth rate of RNAi for Therapeutic in each application, can be divided into
  • Cancer
  • Cardiovascular
  • HBV
Europe RNAi for Therapeutic Market Report 2016

1 RNAI FOR THERAPEUTIC OVERVIEW

1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 Classification of RNAi for Therapeutic
  1.2.1 siRNA
  1.2.2 miRNA
  1.2.3 shRNA
1.3 Application of RNAi for Therapeutic
  1.3.1 Cancer
  1.3.2 Cardiovascular
  1.3.3 HBV
1.4 RNAi for Therapeutic Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of RNAi for Therapeutic (2011-2021)
  1.5.1 Europe RNAi for Therapeutic Sales and Growth Rate (2011-2021)
  1.5.2 Europe RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

2 EUROPE RNAI FOR THERAPEUTIC BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe RNAi for Therapeutic Market Competition by Manufacturers
  2.1.1 Europe RNAi for Therapeutic Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe RNAi for Therapeutic Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe RNAi for Therapeutic (Volume and Value) by Type
  2.2.1 Europe RNAi for Therapeutic Sales and Market Share by Type (2011-2016)
  2.2.2 Europe RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)
2.3 Europe RNAi for Therapeutic (Volume and Value) by Countries
  2.3.1 Europe RNAi for Therapeutic Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe RNAi for Therapeutic Revenue and Market Share by Countries (2011-2016)
2.4 Europe RNAi for Therapeutic (Volume) by Application

3 GERMANY RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

3.1 Germany RNAi for Therapeutic Sales and Value (2011-2016)
  3.1.1 Germany RNAi for Therapeutic Sales and Growth Rate (2011-2016)
  3.1.2 Germany RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
  3.1.3 Germany RNAi for Therapeutic Sales Price Trend (2011-2016)
3.2 Germany RNAi for Therapeutic Sales and Market Share by Manufacturers
3.3 Germany RNAi for Therapeutic Sales and Market Share by Type
3.4 Germany RNAi for Therapeutic Sales and Market Share by Application

4 FRANCE RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

4.1 France RNAi for Therapeutic Sales and Value (2011-2016)
  4.1.1 France RNAi for Therapeutic Sales and Growth Rate (2011-2016)
  4.1.2 France RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
  4.1.4 France RNAi for Therapeutic Sales Price Trend (2011-2016)
4.2 France RNAi for Therapeutic Sales and Market Share by Manufacturers
4.3 France RNAi for Therapeutic Sales and Market Share by Type
4.4 France RNAi for Therapeutic Sales and Market Share by Application

5 UK RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

5.1 UK RNAi for Therapeutic Sales and Value (2011-2016)
  5.1.1 UK RNAi for Therapeutic Sales and Growth Rate (2011-2016)
  5.1.2 UK RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
  5.1.5 UK RNAi for Therapeutic Sales Price Trend (2011-2016)
5.2 UK RNAi for Therapeutic Sales and Market Share by Manufacturers
5.3 UK RNAi for Therapeutic Sales and Market Share by Type
5.4 UK RNAi for Therapeutic Sales and Market Share by Application

6 RUSSIA RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

6.1 Russia RNAi for Therapeutic Sales and Value (2011-2016)
  6.1.1 Russia RNAi for Therapeutic Sales and Growth Rate (2011-2016)
  6.1.2 Russia RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
  6.1.6 Russia RNAi for Therapeutic Sales Price Trend (2011-2016)
6.2 Russia RNAi for Therapeutic Sales and Market Share by Manufacturers
6.3 Russia RNAi for Therapeutic Sales and Market Share by Type
6.4 Russia RNAi for Therapeutic Sales and Market Share by Application

7 ITALY RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

7.1 Italy RNAi for Therapeutic Sales and Value (2011-2016)
  7.1.1 Italy RNAi for Therapeutic Sales and Growth Rate (2011-2016)
  7.1.2 Italy RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
  7.1.7 Italy RNAi for Therapeutic Sales Price Trend (2011-2016)
7.2 Italy RNAi for Therapeutic Sales and Market Share by Manufacturers
7.3 Italy RNAi for Therapeutic Sales and Market Share by Type
7.4 Italy RNAi for Therapeutic Sales and Market Share by Application

8 SPAIN RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

8.1 Spain RNAi for Therapeutic Sales and Value (2011-2016)
  8.1.1 Spain RNAi for Therapeutic Sales and Growth Rate (2011-2016)
  8.1.2 Spain RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
  8.1.8 Spain RNAi for Therapeutic Sales Price Trend (2011-2016)
8.2 Spain RNAi for Therapeutic Sales and Market Share by Manufacturers
8.3 Spain RNAi for Therapeutic Sales and Market Share by Type
8.4 Spain RNAi for Therapeutic Sales and Market Share by Application

9 BENELUX RNAI FOR THERAPEUTIC (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux RNAi for Therapeutic Sales and Value (2011-2016)
  9.1.1 Benelux RNAi for Therapeutic Sales and Growth Rate (2011-2016)
  9.1.2 Benelux RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux RNAi for Therapeutic Sales Price Trend (2011-2016)
9.2 Benelux RNAi for Therapeutic Sales and Market Share by Manufacturers
9.3 Benelux RNAi for Therapeutic Sales and Market Share by Type
9.4 Benelux RNAi for Therapeutic Sales and Market Share by Application

10 EUROPE RNAI FOR THERAPEUTIC MANUFACTURERS ANALYSIS

10.1 Alnylam Pharmaceuticals
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 RNAi for Therapeutic Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Arbutus Biopharma (Tekmira)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 RNAi for Therapeutic Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Arrowhead Research
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 RNAi for Therapeutic Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Arrowhead Research RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Dicerna Pharmaceuticals
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 RNAi for Therapeutic Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Mirna Therapeutics
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 RNAi for Therapeutic Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Quark Pharmaceuticals
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 RNAi for Therapeutic Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 RXi Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 RNAi for Therapeutic Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Silence Therapeutics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 RNAi for Therapeutic Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Benitec Biopharma
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 RNAi for Therapeutic Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Miragen Therapeutics
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 RNAi for Therapeutic Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Miragen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Sylentis
10.12 Gradalis
10.13 Sirnaomics
10.14 Silenseed

11 RNAI FOR THERAPEUTIC MANUFACTURING COST ANALYSIS

11.1 RNAi for Therapeutic Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of RNAi for Therapeutic

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 RNAi for Therapeutic Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE RNAI FOR THERAPEUTIC MARKET FORECAST (2016-2021)

14.1 Germany RNAi for Therapeutic Sales Forecast (2016-2021)
14.2 France RNAi for Therapeutic Sales Forecast (2016-2021)
14.3 UK RNAi for Therapeutic Sales Forecast (2016-2021)
14.4 Russia RNAi for Therapeutic Sales Forecast (2016-2021)
14.5 Italy RNAi for Therapeutic Sales Forecast (2016-2021)
14.6 Spain RNAi for Therapeutic Sales Forecast (2016-2021)
14.7 Benelux RNAi for Therapeutic Sales Forecast (2016-2021)
14.8 Europe RNAi for Therapeutic Sales Forecast by Type (2016-2021)
14.9 Europe RNAi for Therapeutic Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of RNAi for Therapeutic
Table Classification of RNAi for Therapeutic
Figure Europe Sales Market Share of RNAi for Therapeutic by Type in 2015
Figure siRNA Picture
Figure miRNA Picture
Figure shRNA Picture
Table Application of RNAi for Therapeutic
Figure Europe Sales Market Share of RNAi for Therapeutic by Application in 2015
Figure Cancer Examples
Figure Cardiovascular Examples
Figure HBV Examples
Figure Germany RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Figure France RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Figure UK RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Figure Russia RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Figure Italy RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Figure Spain RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Figure Benelux RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Figure Europe RNAi for Therapeutic Sales and Growth Rate (2011-2021)
Figure Europe RNAi for Therapeutic Revenue and Growth Rate (2011-2021)
Table Europe RNAi for Therapeutic Sales of Key Manufacturers (2015 and 2016)
Table Europe RNAi for Therapeutic Sales Share by Manufacturers (2015 and 2016)
Figure 2015 RNAi for Therapeutic Sales Share by Manufacturers
Figure 2016 RNAi for Therapeutic Sales Share by Manufacturers
Table Europe RNAi for Therapeutic Revenue by Manufacturers (2015 and 2016)
Table Europe RNAi for Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe RNAi for Therapeutic Revenue Share by Manufacturers
Table 2016 Europe RNAi for Therapeutic Revenue Share by Manufacturers
Table Europe RNAi for Therapeutic Sales and Market Share by Type (2011-2016)
Table Europe RNAi for Therapeutic Sales Share by Type (2011-2016)
Figure Sales Market Share of RNAi for Therapeutic by Type (2011-2016)
Figure Europe RNAi for Therapeutic Sales Growth Rate by Type (2011-2016)
Table Europe RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)
Table Europe RNAi for Therapeutic Revenue Share by Type (2011-2016)
Figure Revenue Market Share of RNAi for Therapeutic by Type (2011-2016)
Figure Europe RNAi for Therapeutic Revenue Growth Rate by Type (2011-2016)
Table Europe RNAi for Therapeutic Sales and Market Share by Countries (2011-2016)
Table Europe RNAi for Therapeutic Sales Share by Countries (2011-2016)
Figure Sales Market Share of RNAi for Therapeutic by Countries (2011-2016)
Table Europe RNAi for Therapeutic Revenue and Market Share by Countries (2011-2016)
Table Europe RNAi for Therapeutic Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of RNAi for Therapeutic by Countries (2011-2016)
Table Europe RNAi for Therapeutic Sales and Market Share by Application (2011-2016)
Table Europe RNAi for Therapeutic Sales Share by Application (2011-2016)
Figure Sales Market Share of RNAi for Therapeutic by Application (2011-2016)
Figure Germany RNAi for Therapeutic Sales and Growth Rate (2011-2016)
Figure Germany RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
Figure Germany RNAi for Therapeutic Sales Price Trend (2011-2016)
Table Germany RNAi for Therapeutic Sales by Manufacturers (2015 and 2016)
Table Germany RNAi for Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Germany RNAi for Therapeutic Sales by Type (2015 and 2016)
Table Germany RNAi for Therapeutic Market Share by Type (2015 and 2016)
Table Germany RNAi for Therapeutic Sales by Application (2015 and 2016)
Table Germany RNAi for Therapeutic Market Share by Application (2015 and 2016)
Figure France RNAi for Therapeutic Sales and Growth Rate (2011-2016)
Figure France RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
Figure France RNAi for Therapeutic Sales Price Trend (2011-2016)
Table France RNAi for Therapeutic Sales by Manufacturers (2015 and 2016)
Table France RNAi for Therapeutic Market Share by Manufacturers (2015 and 2016)
Table France RNAi for Therapeutic Sales by Type (2015 and 2016)
Table France RNAi for Therapeutic Market Share by Type (2015 and 2016)
Table France RNAi for Therapeutic Sales by Application (2015 and 2016)
Table France RNAi for Therapeutic Market Share by Application (2015 and 2016)
Figure UK RNAi for Therapeutic Sales and Growth Rate (2011-2016)
Figure UK RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
Figure UK RNAi for Therapeutic Sales Price Trend (2011-2016)
Table UK RNAi for Therapeutic Sales by Manufacturers (2015 and 2016)
Table UK RNAi for Therapeutic Market Share by Manufacturers (2015 and 2016)
Table UK RNAi for Therapeutic Sales by Type (2015 and 2016)
Table UK RNAi for Therapeutic Market Share by Type (2015 and 2016)
Table UK RNAi for Therapeutic Sales by Application (2015 and 2016)
Table UK RNAi for Therapeutic Market Share by Application (2015 and 2016)
Figure Russia RNAi for Therapeutic Sales and Growth Rate (2011-2016)
Figure Russia RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
Figure Russia RNAi for Therapeutic Sales Price Trend (2011-2016)
Table Russia RNAi for Therapeutic Sales by Manufacturers (2015 and 2016)
Table Russia RNAi for Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Russia RNAi for Therapeutic Sales by Type (2015 and 2016)
Table Russia RNAi for Therapeutic Market Share by Type (2015 and 2016)
Table Russia RNAi for Therapeutic Sales by Application (2015 and 2016)
Table Russia RNAi for Therapeutic Market Share by Application (2015 and 2016)
Figure Italy RNAi for Therapeutic Sales and Growth Rate (2011-2016)
Figure Italy RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
Figure Italy RNAi for Therapeutic Sales Price Trend (2011-2016)
Table Italy RNAi for Therapeutic Sales by Manufacturers (2015 and 2016)
Table Italy RNAi for Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Italy RNAi for Therapeutic Sales by Type (2015 and 2016)
Table Italy RNAi for Therapeutic Market Share by Type (2015 and 2016)
Table Italy RNAi for Therapeutic Sales by Application (2015 and 2016)
Table Italy RNAi for Therapeutic Market Share by Application (2015 and 2016)
Figure Spain RNAi for Therapeutic Sales and Growth Rate (2011-2016)
Figure Spain RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
Figure Spain RNAi for Therapeutic Sales Price Trend (2011-2016)
Table Spain RNAi for Therapeutic Sales by Manufacturers (2015 and 2016)
Table Spain RNAi for Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Spain RNAi for Therapeutic Sales by Type (2015 and 2016)
Table Spain RNAi for Therapeutic Market Share by Type (2015 and 2016)
Table Spain RNAi for Therapeutic Sales by Application (2015 and 2016)
Table Spain RNAi for Therapeutic Market Share by Application (2015 and 2016)
Figure Benelux RNAi for Therapeutic Sales and Growth Rate (2011-2016)
Figure Benelux RNAi for Therapeutic Revenue and Growth Rate (2011-2016)
Figure Benelux RNAi for Therapeutic Sales Price Trend (2011-2016)
Table Benelux RNAi for Therapeutic Sales by Manufacturers (2015 and 2016)
Table Benelux RNAi for Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Benelux RNAi for Therapeutic Sales by Type (2015 and 2016)
Table Benelux RNAi for Therapeutic Market Share by Type (2015 and 2016)
Table Benelux RNAi for Therapeutic Sales by Application (2015 and 2016)
Table Benelux RNAi for Therapeutic Market Share by Application (2015 and 2016)
Table RNAi for Therapeutic Basic Information List
Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Sales Market Share (2011-2016)
Table Arbutus Biopharma (Tekmira) Basic Information List
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales Market Share (2011-2016)
Table Arrowhead Research Basic Information List
Table Arrowhead Research RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arrowhead Research RNAi for Therapeutic Sales Market Share (2011-2016)
Table Dicerna Pharmaceuticals Basic Information List
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales Market Share (2011-2016)
Table Mirna Therapeutics Basic Information List
Table Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mirna Therapeutics RNAi for Therapeutic Sales Market Share (2011-2016)
Table Quark Pharmaceuticals Basic Information List
Table Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Quark Pharmaceuticals RNAi for Therapeutic Sales Market Share (2011-2016)
Table RXi Pharmaceuticals Basic Information List
Table RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table RXi Pharmaceuticals RNAi for Therapeutic Sales Market Share (2011-2016)
Table Silence Therapeutics Basic Information List
Table Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Silence Therapeutics RNAi for Therapeutic Sales Market Share (2011-2016)
Table Benitec Biopharma Basic Information List
Table Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Benitec Biopharma RNAi for Therapeutic Sales Market Share (2011-2016)
Table Miragen Therapeutics Basic Information List
Table Miragen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Miragen Therapeutics RNAi for Therapeutic Sales Market Share (2011-2016)
Table Sylentis Basic Information List
Table Sylentis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sylentis RNAi for Therapeutic Sales Market Share (2011-2016)
Table Gradalis Basic Information List
Table Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gradalis RNAi for Therapeutic Sales Market Share (2011-2016)
Table Sirnaomics Basic Information List
Table Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sirnaomics RNAi for Therapeutic Sales Market Share (2011-2016)
Table Silenseed Basic Information List
Table Silenseed RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Silenseed RNAi for Therapeutic Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNAi for Therapeutic
Figure Manufacturing Process Analysis of RNAi for Therapeutic
Figure RNAi for Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
Table Major Buyers of RNAi for Therapeutic
Table Distributors/Traders List
Figure Germany RNAi for Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Germany RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure France RNAi for Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure France RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure UK RNAi for Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure UK RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure Russia RNAi for Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Russia RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure Italy RNAi for Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Italy RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure Spain RNAi for Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Spain RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux RNAi for Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Benelux RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table Europe RNAi for Therapeutic Sales Forecast by Type (2016-2021)
Table Europe RNAi for Therapeutic Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories